Studies on binding of HIV-1 p24gag peptide to HLA-Cw3+ cells

Immunol Lett. 1998 Dec;64(2-3):57-62. doi: 10.1016/s0165-2478(98)00079-0.

Abstract

Human major histocompatibility complex class I antigens, HLA-C, are expressed on the cell surface at approximately a tenfold lower level than HLA-A and -B. We hypothesized that the expression of HLA-C is limited by the quantity of high affinity peptides which bind to these molecules, thus allowing only a small fraction of HLA-C molecules to be transported and/or to remain stable on the cell surface. If this assumption is correct, then the addition of exogenous peptide should increase cell surface HLA-C expression. To verify the hypothesis, we pulsed lymphoblastoid cell line PAJ (HLA-Cw3+) with synthetic HIV-1 p24gag 145-152 peptide, known to be presented to T-lymphocytes by HLA-Cw3 molecule. PAJ (HLA-Cw3+) cells bound approximately two times more of the peptide than HAJ (HLA-Cw3-), and four times more than 500/C9 (HLA-Cw3-) cells. Accordingly, overnight pulsing of PAJ cells with the p24gag 145-152 peptide caused an increase in class I HLA expression detected on the cell surface by flow cytofluorimetric analysis with anti-HLA-B,C monoclonal antibodies but not by anti-HLA-A antibody. In contrast, HLA-Cw3- cells treated in the same manner did not show any increase of HLA class I expression. Our data suggest that low concentration of high affinity peptides within the cell may be one of the factors limiting cell surface expression of HLA-C molecules.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Cell Line
  • Female
  • Flow Cytometry
  • Fluorescent Antibody Technique
  • HIV Core Protein p24 / metabolism*
  • HLA-A Antigens / metabolism
  • HLA-B Antigens / metabolism
  • HLA-C Antigens / biosynthesis*
  • Humans
  • Lymphocytes
  • Peptide Fragments / chemical synthesis
  • Peptide Fragments / metabolism

Substances

  • Antibodies, Monoclonal
  • HIV Core Protein p24
  • HLA-A Antigens
  • HLA-B Antigens
  • HLA-C Antigens
  • Peptide Fragments